Another option for less than 50 T4 cells.
D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015277:Hotlines; D006801:Humans; D019469:Indinavir; D019259:Lamivudine; D018579:Patient Selection; D011725:Pyridines / Q000627:therapeutic use*; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use*
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D011725:Pyridines; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D016047:Zalcitabine